Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg, by Health Canada for the treatment of ...
Medicated nasal spray will slash opioid-related hospital admissions
Dr. Victoria Cock, Statewide Clinical Director, Drug and Alcohol Services SA, says demand for free naloxone is growing as ...